Join as an individual or organization
INTRODUCTION: Ecological Momentary Assessment (EMA) can capture fluctuations in an individual’s recovery while minimizing recall bias by collecting real-time data in daily life. Ecological Momentary Interventions (EMIs) build on EMA to...
BACKGROUND:
The expanding role of artificial intelligence (AI) in mental healthcare presents significant opportunities and challenges. AI has the potential to fundamentally transform traditional healthcare practices, particularly in...
Artificial intelligence (AI) is transforming how we understand and manage substance use disorders (SUDs). The following curated readings highlight current developments, practical applications, and ethical considerations for AI in this field...
The article explores how artificial intelligence (AI) is currently used — and could be used — in the field of addiction research and treatment. The authors note that AI (machine learning, data mining, predictive analytics) offers...
AGENDA
2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics
Topic 1: Large Language Models in...
This article reviews the main ethical issues that arise from the use of artificial intelligence (AI) technologies in medicine. Issues around trust, responsibility, risks of discrimination, privacy, autonomy, and potential benefits and harms...
Introduction
Addiction medicine is becoming more of an issue as addiction-related problems continue to plague people all over the globe, resulting in serious health consequences. Addiction has become increasingly prevalent in recent years...
Psychotherapy remains a fundamental component of mental health treatment, yet it encounters significant barriers to accessibility and efficacy. The integration of digital therapies, encompassing e-Health, m-Health...
Addictive substances are prevalent world-wide, and their use presents a substantial and persistent public health problem. A wide range of digital interventions to decrease use and negative consequences thereof have been explored, differing...
Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs.
Methods: Foll...
The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals
Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of Interv...
Background
Smoking is more common in lower socioeconomic position (SEP) groups, but smoking cessation interventions are less effective for these groups. StopCoach, an mHealth intervention, supports people with lower SEP in quitting smoking...
ISSUP, in partnership with the International Consortium of Universities for Drug Demand Reduction (ICUDDR), recently hosted an engaging and forward-looking webinar titled “Reimagining Prevention: The Role of Generative Artificial...
Background
The opioid epidemic in the U.S. contributes to increased morbidity and mortality from drug overdoses, but barriers to traditional opioid use disorder (OUD) treatment limit access to care. During the COVID-19 pandemic, Public...
The World Drug Report (WDR) is published by the United Nations Office on Drugs and Crime (UNODC) (United Nations Office on Drugs and Crime, 2023). It serves to collate data received from United Nations member states which enables the...
The World Drug Report (WDR) is published by the United Nations Office on Drugs and Crime (UNODC) (United Nations Office on Drugs and Crime, 2023). It serves to collate data received from United Nations member states which enables the...
Discussion
Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...